GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 66 weeks on 5mg, full numbers, ask me anything boring — 64 comments in the full submission. View in context.
6.4k
c/glp1science·submitted 1 year ago by u/lina_ndiaye

[Results] 66 weeks on 5mg, full numbers, ask me anything boring

Explainerbranch of 6 comments

Been lurking in c/researchpeptides for about 7 months and finally have something worth posting. Short version: week 58, 10mg, and pharmacology is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 23 threads, and the answers split roughly down the middle. What I actually want…

Read the full submission and all 64 comments →

This branch

6 comments, started 1 year ago
u/amara_dziedzic359 points·1 year ago

Rodent, human, or in vitro?

replysharereportpermalink
u/incretin_ivyMOD197 points·1 year ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
u/lina_ndiayeOP123 points·1 year ago

Receptor distribution explains why injection-site soreness hits pharmacology but not incretin.

replysharereportpermalink
u/hassan_ostergaard57 points·1 year ago

the 11-day half-life means week 11 is still ramp-up pharmacokinetically

replysharereportpermalink
u/analog_alphabet47 points·1 year ago

the 11-day half-life means week 11 is still ramp-up pharmacokinetically

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/lina_ndiayeOP188 points·1 year ago

Stomach physiology changed when I moved up to 15mg. Gastric emptying lag is the whole story.

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/glp1science
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/trialwatch_theou/gastric_emptying_gu/sig_figs_sam
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →